Verastem (VSTM) Shares Outstanding (Weighted Average) (2011 - 2026)
Verastem's quarterly Shares Outstanding (Weighted Average) came in at $98.3 million in Q1 2026, up 81.44% year-on-year from $54.2 million in Q1 2025, and up 1066.09% quarter-over-quarter from $8.4 million in Q4 2025.
Verastem has reported Shares Outstanding (Weighted Average) for 16 years, with the latest figure at $98.3 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 81.44% year-over-year to $98.3 million; the trailing twelve-month figure through Mar 2026 stood at $98.3 million (up 81.44% YoY), and the FY2025 full-year result was $8.4 million, down 53.39% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $98.3 million, up from $8.4 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $186.3 million in Q1 2022, with the low at $8.4 million in Q4 2025.
- Average Shares Outstanding (Weighted Average) over 5 years is $41.5 million, with a median of $22.1 million recorded in 2023.
- Year-over-year, Shares Outstanding (Weighted Average) tumbled 91.02% in 2023 and surged 146.38% in 2025.
- Tracing VSTM's Shares Outstanding (Weighted Average) over 5 years: stood at $16.1 million in 2022, then soared by 36.66% to $22.1 million in 2023, then declined by 18.0% to $18.1 million in 2024, then plunged by 53.39% to $8.4 million in 2025, then jumped by 1066.09% to $98.3 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $98.3 million (Q1 2026), $8.4 million (Q4 2025), and $64.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 16.04 Bn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | 98.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.29 Mn |
| Dec 31, 2025 | 8.43 Mn |
| Sep 30, 2025 | 64.56 Mn |
| Jun 30, 2025 | 66.14 Mn |
| Mar 31, 2025 | 54.17 Mn |
| Dec 31, 2024 | 18.08 Mn |
| Sep 30, 2024 | 31.35 Mn |
| Jun 30, 2024 | 26.85 Mn |
| Mar 31, 2024 | 26.83 Mn |
| Dec 31, 2023 | 22.05 Mn |
| Sep 30, 2023 | 20.45 Mn |
| Jun 30, 2023 | 17.73 Mn |
| Mar 31, 2023 | 16.72 Mn |
| Dec 31, 2022 | 16.14 Mn |
| Sep 30, 2022 | 16.43 Mn |
| Jun 30, 2022 | 15.53 Mn |
| Mar 31, 2022 | 186.26 Mn |
| Dec 31, 2021 | 14.54 Mn |
| Sep 30, 2021 | 179.86 Mn |
| Jun 30, 2021 | 171.99 Mn |
| Mar 31, 2021 | 171.59 Mn |
| Dec 31, 2020 | 153.33 Mn |
| Sep 30, 2020 | 169.51 Mn |
| Jun 30, 2020 | 165.40 Mn |
| Mar 31, 2020 | 108.15 Mn |
| Dec 31, 2019 | 74.58 Mn |
| Sep 30, 2019 | 74.23 Mn |
| Jun 30, 2019 | 73.88 Mn |
| Mar 31, 2019 | 73.85 Mn |
| Dec 31, 2018 | 64.96 Mn |
| Sep 30, 2018 | 73.64 Mn |
| Jun 30, 2018 | 61.26 Mn |
| Mar 31, 2018 | 50.84 Mn |
| Dec 31, 2017 | 38.42 Mn |
| Sep 30, 2017 | 37.21 Mn |
| Jun 30, 2017 | 36.99 Mn |
| Mar 31, 2017 | 36.99 Mn |
| Dec 31, 2016 | 36.99 Mn |
| Sep 30, 2016 | 36.99 Mn |
| Jun 30, 2016 | 36.99 Mn |
| Mar 31, 2016 | 36.98 Mn |
| Dec 31, 2015 | 35.93 Mn |
| Sep 30, 2015 | 36.90 Mn |
| Jun 30, 2015 | 36.52 Mn |
| Mar 31, 2015 | 33.32 Mn |
| Dec 31, 2014 | 25.80 Mn |
| Sep 30, 2014 | 25.81 Mn |
| Jun 30, 2014 | 25.67 Mn |
| Mar 31, 2014 | 25.48 Mn |
| Dec 31, 2013 | 22.68 Mn |
| Sep 30, 2013 | 24.13 Mn |
| Jun 30, 2013 | 20.73 Mn |
| Mar 31, 2013 | 20.48 Mn |
| Dec 31, 2012 | 18.77 Mn |
| Sep 30, 2012 | 20.16 Mn |
| Jun 30, 2012 | 19.86 Mn |
| Mar 31, 2012 | 14.69 Mn |
| Dec 31, 2011 | 1.30 Mn |
| Sep 30, 2011 | 1.36 Mn |
| Jun 30, 2011 | 1.23 Mn |
| Mar 31, 2011 | 1.09 Mn |